Ifrah Financial Services’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-3,000
| Closed | -$33K | – | 213 |
|
2021
Q1 | $33K | Hold |
3,000
| – | – | 0.01% | 206 |
|
2020
Q4 | $14K | Hold |
3,000
| – | – | ﹤0.01% | 192 |
|
2020
Q3 | $17K | Hold |
3,000
| – | – | 0.01% | 177 |
|
2020
Q2 | $17K | Hold |
3,000
| – | – | 0.01% | 179 |
|
2020
Q1 | $16K | Hold |
3,000
| – | – | 0.01% | 165 |
|
2019
Q4 | $19K | Hold |
3,000
| – | – | 0.01% | 195 |
|
2019
Q3 | $10K | Hold |
3,000
| – | – | ﹤0.01% | 184 |
|
2019
Q2 | $12K | Hold |
3,000
| – | – | ﹤0.01% | 185 |
|
2019
Q1 | $11K | Hold |
3,000
| – | – | ﹤0.01% | 185 |
|
2018
Q4 | $9K | Hold |
3,000
| – | – | ﹤0.01% | 172 |
|
2018
Q3 | $16K | Hold |
3,000
| – | – | 0.01% | 202 |
|
2018
Q2 | $14K | Hold |
3,000
| – | – | 0.01% | 187 |
|
2018
Q1 | $13K | Hold |
3,000
| – | – | ﹤0.01% | 188 |
|
2017
Q4 | $12K | Hold |
3,000
| – | – | ﹤0.01% | 196 |
|
2017
Q3 | $15K | Hold |
3,000
| – | – | 0.01% | 191 |
|
2017
Q2 | $19K | Hold |
3,000
| – | – | 0.01% | 184 |
|
2017
Q1 | $18K | Hold |
3,000
| – | – | 0.01% | 186 |
|
2016
Q4 | $17K | Hold |
3,000
| – | – | 0.01% | 188 |
|
2016
Q3 | $22K | Hold |
3,000
| – | – | 0.01% | 190 |
|
2016
Q2 | $26K | Hold |
3,000
| – | – | 0.01% | 194 |
|
2016
Q1 | $27K | Hold |
3,000
| – | – | 0.01% | 191 |
|
2015
Q4 | $28K | Hold |
3,000
| – | – | 0.01% | 187 |
|
2015
Q3 | $42K | Hold |
3,000
| – | – | 0.02% | 193 |
|
2015
Q2 | $44K | Hold |
3,000
| – | – | 0.02% | 200 |
|
2015
Q1 | $47K | Hold |
3,000
| – | – | 0.02% | 201 |
|
2014
Q4 | $44K | Hold |
3,000
| – | – | 0.02% | 196 |
|
2014
Q3 | $51K | Hold |
3,000
| – | – | 0.02% | 204 |
|
2014
Q2 | $94K | Hold |
3,000
| – | – | 0.04% | 199 |
|
2014
Q1 | $66K | Hold |
3,000
| – | – | 0.03% | 198 |
|
2013
Q4 | $15K | Hold |
3,000
| – | – | 0.01% | 193 |
|
2013
Q3 | $20K | Hold |
3,000
| – | – | 0.01% | 107 |
|
2013
Q2 | $14K | Buy |
+3,000
| New | +$14K | 0.01% | 107 |
|